Table 1.
Type of MSCs | Tumor propagating effect | Tumor inhibiting effect |
---|---|---|
Bone marrow | Acute lymphoblastic leukemia | Hepatocellular carcinoma |
Acute myeoblastic leukemia | Pancreatic cancer | |
Chronic lymphocytic leukemia | Glioma | |
Lymphoma | ||
Multiple myeloma | ||
Breast cancer | ||
Hepatocellular carcinoma | ||
Colorectal cancer | ||
Colon cancer | ||
Prostate cancer | ||
Renal cell carcinoma | ||
Endometrial tumors | ||
Glioma | ||
Osteosarcoma | ||
Prostate cancer | ||
Ovarian cancer | ||
Gastric cancer | ||
Pancreatic cancer | ||
Lung cancer | ||
Oral tongue tumor | ||
Adipose tissues | Acute lymphoblastic leukemia | Murine T-cell lymphoma |
Acute promyelocytic leukemia | Multiple myeloma | |
Chronic lymphocytic leukemia | Hepatic cancer | |
Breast cancer | Colorectal adenocarcinoma | |
Lung cancer | Prostate cancer | |
Ovarian cancer | Glioma | |
Prostate cancer | Melanoma | |
Kaposi sarcoma | ||
Melanoma tumor | ||
Colon cancer | ||
Prostate cancer | ||
Endometrial tumors | ||
Glioma | ||
Head/neck cancer | ||
Umbilical cord/cord Blood | Acute lymphoblastic leukemia | Acute lymphoblastic leukemia |
Acute myeoblastic leukemia | Chronic myeloid leukemia in blast crisis | |
Breast cancer | Acute myeoblastic leukemia | |
Gastric epithelial cell | Burkitt's lymphoma | |
Esophageal cancer | Multiple myeloma | |
Mouse pancreatic cancer | Breast cancer | |
Ovarian cancer | Hepatic cancer | |
Cholangiocarcinoma | ||
Bronchioloalveolar carcinoma | ||
Prostate cancer | ||
Bladder tumor | ||
Ovarian carcinoma | ||
Glioma | ||
Esophageal cancer | ||
Lung cancer |
Note: Distinct MSCs come from different origins and exhibit a diverse range of anticancer properties. The MSCs from bone marrow and adipose tissues mainly show tumor-propagating effects; however, MSCs from umbilical cord/cord blood mainly show tumor-inhibiting effects.